Publications Date
Authors
Mark W Tenforde, Thandi Milton, Ikanyeng Rulaganyang, Charles Muthoga, Leabaneng Tawe, Tom Chiller, Gregory Greene, Alexander Jordan, Christopher G Williams, Leah Owen, Tshepo B Leeme, Amber Boose, Julia Ngidi, Madisa Mine, Joseph N Jarvis
PMID
32604411
PMCID
PMC8096249
DOI
10.1093/cid/ciaa899
Abstract

Increasing the CD4-count threshold for cryptococcal antigen (CrAg) screening from ≤100 to ≤200 cells/µL resulted in a 3-fold increase in numbers screened. CrAg-prevalence was 3.5% at CD4 101-200 and 6.2% ≤100 cells/µL. Six-month mortality was 21.4% (9/42) in CrAg-positive CD4 ≤100 cells/µL and 3.2% (1/31) in CrAg-positive CD4 101-200 cells/µL.

Document
Outcomes_of_Re_ex_Cryptococcal_Antigen_(CrAg)_Screening_in_Human_Immunode_ciency_Virus_(HIV)_Positive_Patients_With_CD4_Counts_of_100_200_Cells:μL_in_Botswana.pdf
https://pubmed.ncbi.nlm.nih.gov/32604411/